Cambridge Cognition Holdings (LSE:COG) Short Ratio


LSE:COG Cambridge Cognition Holdings PLC LSE:COG
48 GF Score
Price £0.32
GF Value £0.33
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Cambridge Cognition Holdings Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

LSE:COG
48GF Score
Cambridge Cognition Holdings PLC LSE:COG
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Cambridge Cognition Holdings (LSE:COG) Overvalued in 2026?

Based on GuruFocus' analysis, Cambridge Cognition Holdings stock appears to be undervalued. The current stock price of £0.32 is trading 4.5% below its estimated GF Value™ of £0.33. GuruFocus considers Cambridge Cognition Holdings to be Fairly Valued.

Key valuation signals for LSE:COG:

  • Short Ratio:
  • GF Value™: £0.33 vs. price of £0.32 (4.5% below fair value)
  • GF Score™: 48/100 with 5 warning signs

No single metric tells the full story. See the LSE:COG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cambridge Cognition Holdings Business Description

Other Exchanges 1M7:Germany
Address Tunbridge Lane, Tunbridge Court, Bottisham, Cambridge, GBR, CB25 9TU
Cambridge Cognition Holdings PLC is a neuroscience digital health company specializing in the measurement of clinical outcomes in neurological disorders. It develops and commercialises neuroscience technologies to assess cognitive function for sale across the world. The company's products include CANTAB web-based assessments, Electronic questionnaires and scales (eCOA), NeuroVocalix Winterlight, a voice analysis tool to assess cognitive changes, high-frequency testing kits, and Clinpal, among others. Its operating segments are: Clinical studies, which generate maximum revenue, Academic research, Professional Healthcare, and Consumer Health & Wellness. Geographically, the company generates maximum revenue from the USA, and the rest from the UK, the European Union, and the Rest of the world.
48GF Score

Get the complete analysis for LSE:COG

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£0.32
Price
£0.33
GF Value